We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
631
Increased
3,220
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENG
3876
DELISTED
ENGlobal Corp
ENG
$22K ﹤0.01%
2,209
+1,746
+377% +$19.7K
GOL
3877
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$22K ﹤0.01%
6,731
-7,650
-53% -$28.2K
CVT
3878
DELISTED
Cvent Holding Corp. Common Stock
CVT
$22K ﹤0.01%
4,193
-7,832
-65% -$44.5K
ABUS icon
3879
Arbutus Biopharma
ABUS
$924M
$21K ﹤0.01%
10,648
-5,375
-34% -$12.7K
ADTX
3880
DELISTED
ADITXT INC
ADTX
– –
0
– –
AHT
3881
Ashford Hospitality Trust
AHT
$20.8M
$21K ﹤0.01%
316
+193
+157% +$17.1K
ANEB
3882
DELISTED
Anebulo Pharmaceuticals
ANEB
$21K ﹤0.01%
7,330
+189
+3% +$671
BHR
3883
Braemar Hotels & Resorts
BHR
$139M
$21K ﹤0.01%
4,985
-8,977
-64% -$45.5K
BLND icon
3884
Blend Labs
BLND
$352M
$21K ﹤0.01%
9,387
-14,727
-61% -$41.8K
BND icon
3885
Vanguard Total Bond Market
BND
$161B
$21K ﹤0.01%
290
-37
-11% -$2.77K
CAN
3886
Canaan Creative
CAN
$171M
$21K ﹤0.01%
6,322
-5,325
-46% -$19.4K
CLS icon
3887
Celestica
CLS
$42.3B
$21K ﹤0.01%
2,444
+2,265
+1,265% +$23K
CNTA
3888
DELISTED
Centessa Pharmaceuticals
CNTA
$21K ﹤0.01%
5,277
+3,800
+257% +$17.4K
CNTB
3889
Connect Biopharma Holdings
CNTB
$161M
$21K ﹤0.01%
16,210
-615
-4% -$739
EPSN icon
3890
Epsilon Energy
EPSN
$169M
$21K ﹤0.01%
3,264
-128
-4% -$833
EQX icon
3891
Equinox Gold
EQX
$13.5B
$21K ﹤0.01%
5,741
-13,129
-70% -$51.1K
GIC icon
3892
Global Industrial
GIC
$1.48B
$21K ﹤0.01%
782
+253
+48% +$7.97K
GRND icon
3893
Grindr
GRND
$2.78B
$21K ﹤0.01%
2,070
+182
+10% +$1.88K
GROW icon
3894
US Global Investors
GROW
$39.4M
$21K ﹤0.01%
7,081
+6,587
+1,333% +$25.6K
HAYW icon
3895
Hayward Holdings
HAYW
$3.22B
$21K ﹤0.01%
2,399
+1,542
+180% +$18.1K
LXFR icon
3896
Luxfer Holdings
LXFR
$457M
$21K ﹤0.01%
1,464
+905
+162% +$14.3K
MGV icon
3897
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.8B
$21K ﹤0.01%
238
-2,279
-91% -$224K
OBIO icon
3898
Orchestra BioMed
OBIO
$265M
$21K ﹤0.01%
2,123
+984
+86% +$9.76K
OCSL icon
3899
Oaktree Specialty Lending
OCSL
$1.14B
$21K ﹤0.01%
1,193
-7,880
-87% -$160K
PAVM icon
3900
PAVmed
PAVM
$37.2M
$21K ﹤0.01%
+54
New +$30.6K
154 155
156
157 158

Similar funds

AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 44.45% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 631 new positions and adding to 3,220 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 631 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.